img

Global Hemophilia Treatment Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Hemophilia Treatment Market Research Report 2024

Hemophilia is a hereditary genetic disorder which impairs body’s ability to control coagulation or blood clotting. In this disease, clotting factors control bleeding from a broken vessel is deficient; therefore, coagulation does not occur. Of the two types of hemophilia, hemophilia A has higher prevalence compared to the other variant hemophilia B. . Acquired hemophilia is a rare non genetic form of hemophilia in which autoantibodies develop against the plasma coagulation factor. The development of novel coagulating factors and technological advancements are driving the growth of this market. Lack of available medicines, awareness of this disease and high cost of treatment are the major restraining factors in this market. The advancements in gene Therapy and approaching approval of drugs for treatment of hemophilia provide growth opportunities in this market.
According to Mr Accuracy reports’s new survey, global Hemophilia Treatment market is projected to reach US$ million in 2034, increasing from US$ million in 2024, with the CAGR of % during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Hemophilia Treatment market research.
Key companies engaged in the Hemophilia Treatment industry include CSL Behring, Baxalta, Pfizer Inc, BioMarin, Bayer Healthcare, Biogen, Novo Nordisk, Roche and Takeda, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % value of Hemophilia Treatment were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Hemophilia Treatment market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Hemophilia Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


CSL Behring
Baxalta
Pfizer Inc
BioMarin
Bayer Healthcare
Biogen
Novo Nordisk
Roche
Takeda
Segment by Type
On-demand
Prophylaxis

Segment by Application


Replacement Therapy
ITI Therapy
Gene Therapy
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Hemophilia Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hemophilia Treatment Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 On-demand
1.2.3 Prophylaxis
1.3 Market by Application
1.3.1 Global Hemophilia Treatment Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Replacement Therapy
1.3.3 ITI Therapy
1.3.4 Gene Therapy
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hemophilia Treatment Market Perspective (2018-2034)
2.2 Hemophilia Treatment Growth Trends by Region
2.2.1 Global Hemophilia Treatment Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 Hemophilia Treatment Historic Market Size by Region (2018-2023)
2.2.3 Hemophilia Treatment Forecasted Market Size by Region (2024-2034)
2.3 Hemophilia Treatment Market Dynamics
2.3.1 Hemophilia Treatment Industry Trends
2.3.2 Hemophilia Treatment Market Drivers
2.3.3 Hemophilia Treatment Market Challenges
2.3.4 Hemophilia Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hemophilia Treatment Players by Revenue
3.1.1 Global Top Hemophilia Treatment Players by Revenue (2018-2023)
3.1.2 Global Hemophilia Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Hemophilia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hemophilia Treatment Revenue
3.4 Global Hemophilia Treatment Market Concentration Ratio
3.4.1 Global Hemophilia Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hemophilia Treatment Revenue in 2024
3.5 Hemophilia Treatment Key Players Head office and Area Served
3.6 Key Players Hemophilia Treatment Product Solution and Service
3.7 Date of Enter into Hemophilia Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hemophilia Treatment Breakdown Data by Type
4.1 Global Hemophilia Treatment Historic Market Size by Type (2018-2023)
4.2 Global Hemophilia Treatment Forecasted Market Size by Type (2024-2034)
5 Hemophilia Treatment Breakdown Data by Application
5.1 Global Hemophilia Treatment Historic Market Size by Application (2018-2023)
5.2 Global Hemophilia Treatment Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Hemophilia Treatment Market Size (2018-2034)
6.2 North America Hemophilia Treatment Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America Hemophilia Treatment Market Size by Country (2018-2023)
6.4 North America Hemophilia Treatment Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hemophilia Treatment Market Size (2018-2034)
7.2 Europe Hemophilia Treatment Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe Hemophilia Treatment Market Size by Country (2018-2023)
7.4 Europe Hemophilia Treatment Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hemophilia Treatment Market Size (2018-2034)
8.2 Asia-Pacific Hemophilia Treatment Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific Hemophilia Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Hemophilia Treatment Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hemophilia Treatment Market Size (2018-2034)
9.2 Latin America Hemophilia Treatment Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America Hemophilia Treatment Market Size by Country (2018-2023)
9.4 Latin America Hemophilia Treatment Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hemophilia Treatment Market Size (2018-2034)
10.2 Middle East & Africa Hemophilia Treatment Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa Hemophilia Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Hemophilia Treatment Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 CSL Behring
11.1.1 CSL Behring Company Detail
11.1.2 CSL Behring Business Overview
11.1.3 CSL Behring Hemophilia Treatment Introduction
11.1.4 CSL Behring Revenue in Hemophilia Treatment Business (2018-2023)
11.1.5 CSL Behring Recent Development
11.2 Baxalta
11.2.1 Baxalta Company Detail
11.2.2 Baxalta Business Overview
11.2.3 Baxalta Hemophilia Treatment Introduction
11.2.4 Baxalta Revenue in Hemophilia Treatment Business (2018-2023)
11.2.5 Baxalta Recent Development
11.3 Pfizer Inc
11.3.1 Pfizer Inc Company Detail
11.3.2 Pfizer Inc Business Overview
11.3.3 Pfizer Inc Hemophilia Treatment Introduction
11.3.4 Pfizer Inc Revenue in Hemophilia Treatment Business (2018-2023)
11.3.5 Pfizer Inc Recent Development
11.4 BioMarin
11.4.1 BioMarin Company Detail
11.4.2 BioMarin Business Overview
11.4.3 BioMarin Hemophilia Treatment Introduction
11.4.4 BioMarin Revenue in Hemophilia Treatment Business (2018-2023)
11.4.5 BioMarin Recent Development
11.5 Bayer Healthcare
11.5.1 Bayer Healthcare Company Detail
11.5.2 Bayer Healthcare Business Overview
11.5.3 Bayer Healthcare Hemophilia Treatment Introduction
11.5.4 Bayer Healthcare Revenue in Hemophilia Treatment Business (2018-2023)
11.5.5 Bayer Healthcare Recent Development
11.6 Biogen
11.6.1 Biogen Company Detail
11.6.2 Biogen Business Overview
11.6.3 Biogen Hemophilia Treatment Introduction
11.6.4 Biogen Revenue in Hemophilia Treatment Business (2018-2023)
11.6.5 Biogen Recent Development
11.7 Novo Nordisk
11.7.1 Novo Nordisk Company Detail
11.7.2 Novo Nordisk Business Overview
11.7.3 Novo Nordisk Hemophilia Treatment Introduction
11.7.4 Novo Nordisk Revenue in Hemophilia Treatment Business (2018-2023)
11.7.5 Novo Nordisk Recent Development
11.8 Roche
11.8.1 Roche Company Detail
11.8.2 Roche Business Overview
11.8.3 Roche Hemophilia Treatment Introduction
11.8.4 Roche Revenue in Hemophilia Treatment Business (2018-2023)
11.8.5 Roche Recent Development
11.9 Takeda
11.9.1 Takeda Company Detail
11.9.2 Takeda Business Overview
11.9.3 Takeda Hemophilia Treatment Introduction
11.9.4 Takeda Revenue in Hemophilia Treatment Business (2018-2023)
11.9.5 Takeda Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Hemophilia Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of On-demand
Table 3. Key Players of Prophylaxis
Table 4. Global Hemophilia Treatment Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 5. Global Hemophilia Treatment Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 6. Global Hemophilia Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Hemophilia Treatment Market Share by Region (2018-2023)
Table 8. Global Hemophilia Treatment Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 9. Global Hemophilia Treatment Market Share by Region (2024-2034)
Table 10. Hemophilia Treatment Market Trends
Table 11. Hemophilia Treatment Market Drivers
Table 12. Hemophilia Treatment Market Challenges
Table 13. Hemophilia Treatment Market Restraints
Table 14. Global Hemophilia Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Hemophilia Treatment Market Share by Players (2018-2023)
Table 16. Global Top Hemophilia Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemophilia Treatment as of 2024)
Table 17. Ranking of Global Top Hemophilia Treatment Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Hemophilia Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Hemophilia Treatment Product Solution and Service
Table 21. Date of Enter into Hemophilia Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Hemophilia Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Hemophilia Treatment Revenue Market Share by Type (2018-2023)
Table 25. Global Hemophilia Treatment Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 26. Global Hemophilia Treatment Revenue Market Share by Type (2024-2034)
Table 27. Global Hemophilia Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Hemophilia Treatment Revenue Market Share by Application (2018-2023)
Table 29. Global Hemophilia Treatment Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 30. Global Hemophilia Treatment Revenue Market Share by Application (2024-2034)
Table 31. North America Hemophilia Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 32. North America Hemophilia Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Hemophilia Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 34. Europe Hemophilia Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 35. Europe Hemophilia Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Hemophilia Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 37. Asia-Pacific Hemophilia Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 38. Asia-Pacific Hemophilia Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Hemophilia Treatment Market Size by Region (2024-2034) & (US$ Million)
Table 40. Latin America Hemophilia Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 41. Latin America Hemophilia Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Hemophilia Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 43. Middle East & Africa Hemophilia Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 44. Middle East & Africa Hemophilia Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Hemophilia Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 46. CSL Behring Company Detail
Table 47. CSL Behring Business Overview
Table 48. CSL Behring Hemophilia Treatment Product
Table 49. CSL Behring Revenue in Hemophilia Treatment Business (2018-2023) & (US$ Million)
Table 50. CSL Behring Recent Development
Table 51. Baxalta Company Detail
Table 52. Baxalta Business Overview
Table 53. Baxalta Hemophilia Treatment Product
Table 54. Baxalta Revenue in Hemophilia Treatment Business (2018-2023) & (US$ Million)
Table 55. Baxalta Recent Development
Table 56. Pfizer Inc Company Detail
Table 57. Pfizer Inc Business Overview
Table 58. Pfizer Inc Hemophilia Treatment Product
Table 59. Pfizer Inc Revenue in Hemophilia Treatment Business (2018-2023) & (US$ Million)
Table 60. Pfizer Inc Recent Development
Table 61. BioMarin Company Detail
Table 62. BioMarin Business Overview
Table 63. BioMarin Hemophilia Treatment Product
Table 64. BioMarin Revenue in Hemophilia Treatment Business (2018-2023) & (US$ Million)
Table 65. BioMarin Recent Development
Table 66. Bayer Healthcare Company Detail
Table 67. Bayer Healthcare Business Overview
Table 68. Bayer Healthcare Hemophilia Treatment Product
Table 69. Bayer Healthcare Revenue in Hemophilia Treatment Business (2018-2023) & (US$ Million)
Table 70. Bayer Healthcare Recent Development
Table 71. Biogen Company Detail
Table 72. Biogen Business Overview
Table 73. Biogen Hemophilia Treatment Product
Table 74. Biogen Revenue in Hemophilia Treatment Business (2018-2023) & (US$ Million)
Table 75. Biogen Recent Development
Table 76. Novo Nordisk Company Detail
Table 77. Novo Nordisk Business Overview
Table 78. Novo Nordisk Hemophilia Treatment Product
Table 79. Novo Nordisk Revenue in Hemophilia Treatment Business (2018-2023) & (US$ Million)
Table 80. Novo Nordisk Recent Development
Table 81. Roche Company Detail
Table 82. Roche Business Overview
Table 83. Roche Hemophilia Treatment Product
Table 84. Roche Revenue in Hemophilia Treatment Business (2018-2023) & (US$ Million)
Table 85. Roche Recent Development
Table 86. Takeda Company Detail
Table 87. Takeda Business Overview
Table 88. Takeda Hemophilia Treatment Product
Table 89. Takeda Revenue in Hemophilia Treatment Business (2018-2023) & (US$ Million)
Table 90. Takeda Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hemophilia Treatment Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Hemophilia Treatment Market Share by Type: 2024 VS 2034
Figure 3. On-demand Features
Figure 4. Prophylaxis Features
Figure 5. Global Hemophilia Treatment Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 6. Global Hemophilia Treatment Market Share by Application: 2024 VS 2034
Figure 7. Replacement Therapy Case Studies
Figure 8. ITI Therapy Case Studies
Figure 9. Gene Therapy Case Studies
Figure 10. Hemophilia Treatment Report Years Considered
Figure 11. Global Hemophilia Treatment Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 12. Global Hemophilia Treatment Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 13. Global Hemophilia Treatment Market Share by Region: 2024 VS 2034
Figure 14. Global Hemophilia Treatment Market Share by Players in 2024
Figure 15. Global Top Hemophilia Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemophilia Treatment as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Hemophilia Treatment Revenue in 2024
Figure 17. North America Hemophilia Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 18. North America Hemophilia Treatment Market Share by Country (2018-2034)
Figure 19. United States Hemophilia Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 20. Canada Hemophilia Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 21. Europe Hemophilia Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 22. Europe Hemophilia Treatment Market Share by Country (2018-2034)
Figure 23. Germany Hemophilia Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 24. France Hemophilia Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. U.K. Hemophilia Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. Italy Hemophilia Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. Russia Hemophilia Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. Nordic Countries Hemophilia Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Asia-Pacific Hemophilia Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Asia-Pacific Hemophilia Treatment Market Share by Region (2018-2034)
Figure 31. China Hemophilia Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Japan Hemophilia Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. South Korea Hemophilia Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. Southeast Asia Hemophilia Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. India Hemophilia Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. Australia Hemophilia Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. Latin America Hemophilia Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. Latin America Hemophilia Treatment Market Share by Country (2018-2034)
Figure 39. Mexico Hemophilia Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 40. Brazil Hemophilia Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. Middle East & Africa Hemophilia Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Middle East & Africa Hemophilia Treatment Market Share by Country (2018-2034)
Figure 43. Turkey Hemophilia Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. Saudi Arabia Hemophilia Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. CSL Behring Revenue Growth Rate in Hemophilia Treatment Business (2018-2023)
Figure 46. Baxalta Revenue Growth Rate in Hemophilia Treatment Business (2018-2023)
Figure 47. Pfizer Inc Revenue Growth Rate in Hemophilia Treatment Business (2018-2023)
Figure 48. BioMarin Revenue Growth Rate in Hemophilia Treatment Business (2018-2023)
Figure 49. Bayer Healthcare Revenue Growth Rate in Hemophilia Treatment Business (2018-2023)
Figure 50. Biogen Revenue Growth Rate in Hemophilia Treatment Business (2018-2023)
Figure 51. Novo Nordisk Revenue Growth Rate in Hemophilia Treatment Business (2018-2023)
Figure 52. Roche Revenue Growth Rate in Hemophilia Treatment Business (2018-2023)
Figure 53. Takeda Revenue Growth Rate in Hemophilia Treatment Business (2018-2023)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries